Page 31 - Markets

Lumax Auto zooms 147% in CY2025; beats SmallCap index for 4th straight year

Lumax Auto is well positioned to benefit from both volume growth and premiumization trends across top OEMs, believe analysts

Mexico tariff hike to weigh on Indian auto, aluminium exports: JM Financial

Last week, Mexico approved a bill to raise tariffs on more than 1,400 imported goods from Asian countries, effective 1 January 2026

Corona Remedies makes bumper D-St debut; lists at 38% premium on bourses

Corona Remedies shares opened at ₹1,470 on the NSE, a premium of ₹408 or 38 per cent from the issue price of ₹1,062

Geojit Financial shares soar after 15% equity traded in multiple blocks

Geojit Financial shares rose after about 42 million shares, or 15 per cent equity, changed hands on Monday, according to Bloomberg

Urban Company slides 6%, PhysicsWallah dips 2%; here's why stocks fell

Urban Company and declined on Monday, likely due to selling by institutional investors following the expiry of the lock-in period

Wakefit Innovations makes flat D-Street debut; misses IPO GMP estimates

Wakefit Innovations shares began trading at ₹195 per share on the NSE, the same as the IPO issue price, while on the BSE they opened at ₹194.10 per share, down 0.46 per cent from the issue price

Elara Capital retains BUY, but lowers TP on Kaynes Tech by 30%; key details

Elara Capital believes that the recent market reaction to Kaynes Technology accounting inconsistency was disproportionate and shall have no material impact on the company's earnings.

Elara Capital bets on JSW Infra's strategic expansion; upgrades to 'Buy'

The brokerage expects Ebitda to more than triple from ₹2,300 crore in FY25 to ₹7,200 crore by FY30E

Capex revival, policy tailwinds to aid Siemens; Antique sees 20% upside

Antique maintains its 'Buy' rating on Siemens with a target price of ₹3,767 per share, an upside of nearly 20 per cent from Friday's close

Smallcaps may see more pain in 2026; Nifty target at 30,548: Vikram Kasat

Mid-caps are poised to lead over large- and small-caps in 2026, driven by double-digit FY27 earnings and FPI inflows, though outperformance margins may narrow, said Vikram Kasat of PL Capital

HDFC Sec says 'Buy' again on JK Lakshmi Cement; 5 drivers behind the call

HDFC Securities estimates JK Lakshmi Cement will deliver a 10 per cent volume CAGR during FY25-FY28, with margins recovering to ₹986 per tonne in FY28E from ₹713 per tonne in FY25

Nephrocare Health IPO allotment today; check status, GMP, listing date

Applicants can check their Nephrocare Health IPO allotment status on the official websites of NSE and BSE, or the registrar Kfin Technologies

India's equity markets, economy: Will investors update their beliefs?

The Nifty is a club of giants - banks, financiers, software firms, pharmaceuticals, consumer staples, and commodity producers

Would like to build Unity Bank before IPO to create best value: Bindra

Centrum Group Chief Jaspal Bindra outlines unity bank's expansion strategy, universal bank ambitions and IPO timeline, alongside plans for portfolio diversification and capital strength

Outlook bright for auto financiers, but valuations may cap upside: Analysts

Vehicle financiers gain double digits in FY26 as AUM, NIMs and auto loan demand rise. Analysts turn positive on Shriram Finance, M&M Finance, Cholamandalam Investment, and Bajaj Finance

Why India’s 2025 IPO wave failed retail investors

India saw 232 IPOs in 2025, a record year. But behind the frenzy was a harsh truth: from tech unicorns to big consumer brands, many of the year’s most hyped IPOs failed to deliver returns.

Stock Market Highlights: Sensex ends 450 pts higher; Nifty at 26,047; Metal, realty lead rally

Sensex Today | Stock Market Highlights, December 12, 2025: In the broader markets, the Nifty MidCap index advanced 1.18 per cent, and the Nifty SmallCap index 0.94 per cent

Silver prices breach ₹2-lakh milestone as 2025 rally soars to nearly 130%

Axis Securities maintains a constructive outlook on silver, citing multiple tailwinds that continue to sustain the rally even as valuations stretch

IPO Calendar: Busy week; ICICI Pru AMC, Corona Remedies debut in focus

Upcoming IPO Calendar: Corona Remedies and Wakefit Innovations are set to debut on Friday, December 15, followed by Nephrocare Health and Park Medi World, both scheduled to list on Sunday, December 17

Corona Remedies IPO to list on Dec 15; here's what GMP hints for D-St debut

Corona Remedies IPO received an overwhelming investor interest, achieving an overall oversubscription of 137 times, driven largely by strong participation from QIBs